InterWest Venture Management’s PMV Pharmaceuticals PMVP Stock Holding History

InterWest Venture Management’s Portfolio PMVP Stock Details PMVP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$9.92M	Hold	1,614,911	–	–	48.05%	1
2023 Q2	$10.1M	Hold	1,614,911	–	–	41.23%	1
2023 Q1	$7.7M	Hold	1,614,911	–	–	37.02%	2
2022 Q4	$14M	Hold	1,614,911	–	–	67.54%	1
2022 Q3	$19.2M	Hold	1,614,911	–	–	59.24%	1
2022 Q2	$23M	Sell	1,614,911 -1,620,000	-50%	-$23.6M	42.78%	1
2022 Q1	$67.4M	Hold	3,234,911	–	–	25.73%	2
2021 Q4	$74.7M	Sell	3,234,911 -635,000	-16%	-$15.3M	44.17%	1
2021 Q3	$115M	Sell	3,869,911 -1,100,000	-22%	-$35.1M	47.76%	1
2021 Q2	$170M	Sell	4,969,911 -500,000	-9%	-$16.7M	53.57%	1
2021 Q1	$180M	Sell	5,469,911 -1,000,000	-15%	-$39.4M	47.32%	1
2020 Q4	$398M	Hold	6,469,911	–	–	49.71%	1
2020 Q3	$230M	Buy	+6,469,911	New	+$238M	66.28%	1

Other funds holding PMVP

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

InterWest Venture Management's PMVP Position: Q3 2023 in Review

InterWest Venture Management held its PMV Pharmaceuticals (PMVP) position steady in Q3 2023 at 1,614,911 shares worth $9.92M. The position accounts for 48.05% of the portfolio, ranked #1.

InterWest Venture Management first reported a position in PMVP in Q3 2020 and has held it in 13 quarters since. The position peaked at $398M in Q4 2020. 104 funds tracked by Wall St. Rank hold PMVP as of Q3 2023.

InterWest Venture Management held 1,614,911 shares of PMV Pharmaceuticals worth $9.92M as of Q3 2023.
InterWest Venture Management left its PMV Pharmaceuticals share count unchanged in Q3 2023.
PMV Pharmaceuticals made up 48.05% of InterWest Venture Management's portfolio in Q3 2023, its #1 holding.
InterWest Venture Management first reported a position in PMV Pharmaceuticals in Q3 2020 and has held it in 13 quarters since.
InterWest Venture Management's PMV Pharmaceuticals position peaked at $398M in Q4 2020.
104 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2023.

Based on InterWest Venture Management's 13F filing for Q3 2023, filed 20 Oct 2023.